ADA Scientific Sessions 2026 Abstract·5 JunEfficacy and Safety of Anagliptin Added to Metformin and Empagliflozin 25 mg in Patients with Type 2 Diabetes: A 24-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with 28-Week Open-Label ExtensionTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunComparative Effects of Enavogliflozin vs. Dapagliflozin on Adipokines in Patients with Type 2 Diabetes MellitusTrial in peopleInterventionsPaper